¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phage cross"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® phage ÇÑ±Û ÆÄÁö
¼³¸í   
  ¼¼±ÕÀ» ¿ëÇØ½Ã۴ ¹ÙÀÌ·¯½º. *¹ÚÅ׸®¿ÀÆÄÁö ÂüÁ¶.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • defective phage
    °á¼ÕÆÄÁö
  • donor-specific phage
    Á¦°øÀÚÆ¯ÀÌÆÄÁö, °ø¿©ÀÚÆ¯ÀÌÆÄÁö
  • helper phage
    µµ¿òÆÄÁö, Á¶·ÂÆÄÁö
  • inducible phage
    À¯¹ßÆÄÁö
  • latent phage
    ÀáÀçÆÄÁö
  • phage
    ÆÄÁö
  • phage genome
    ÆÄÁöÀ¯Àüü
  • temperate phage
    ¿Â¼øÆÄÁö
  • temperature-sensitive phage
    ¿Âµµ¹Î°¨ÆÄÁö
  • vegetative phage
    Áõ½ÄÇüÆÄÁö
  • virulent phage
    µ¶¼ºÆÄÁö, ¿ë±Õ¼ºÆÄÁö
  • blue cross
    û½ÊÀÚ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross
    ±³Â÷
  • cross absorption
    ±³Â÷Èí¼ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phage
    ÆÄÁö
  • cross
    ±³Â÷
  • cross matching
    ±³Â÷½ÃÇè
  • cross reaction
    ±³Â÷¹ÝÀÀ
  • cross-sectional study
    ´Ü¸éÁ¶»ç¿¬±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phage conversion
    ÆÄÁöÀüȯ, ÆÄÁö±³È¯
  • defective phage
    °á¼ÕÆÄÁö
  • donor-specific phage
    Á¦°øÃ¼Æ¯ÀÌÆÄÁö, ÁÖ°ÔÆ¯ÀÌÆÄÁö
  • phage genome
    ÆÄÁöÀ¯Àüü
  • helper phage
    º¸Á¶ÆÄÁö, Á¶·ÂÆÄÁö
  • inducible phage
    À¯¹ß°¡´ÉÆÄÁö
  • latent phage
    ÀáÀçÆÄÁö
  • phage map
    ÆÄÁöÀ¯ÀüÀÚÁöµµ
  • phage
    ÆÄÁö
  • phage plaque-forming unit
    ÆÄÁö¿ë±ÕÇü¼º´ÜÀ§, ÆÄÁöÇöóÅ©Çü¼º´ÜÀ§
  • temperate phage
    ÀáÀçÆÄÁö, ¿Â¼øÆÄÁö
  • temperature-sensitive phage
    ¿Âµµ¹Î°¨ÆÄÁö
  • transducing phage
    ÇüÁúµµÀÔÆÄÁö
  • vegetative phage
    Áõ½ÄÇüÆÄÁö
  • virulent phage
    ¿ë±Õ¼ºÆÄÁö, µ¶¼ºÆÄÁö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cross bridge
    ±³Â÷°áÇÕ(Îßó©Ì¿ùê), ¿¬°á±³
  • Cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â(Îßó©Ì¿ùêñÎÑ¢)
  • Cross-Bevan reagent
    Å©·Î½º-º£¹Ý½Ã¾à.
  • Jackson cross cylinder
    Àè½¼±³Â÷¿øÁÖ(·»Áî)
  • absorption, cross
    ±³Â÷Èí¼ö½ÃÇè
  • antibody, cross-reacting
    ±³Â÷¹ÝÀÀÇ×ü
  • antigen, cross-reacting
    ±³Â÷¹ÝÀÀÇ׿ø
  • genus cross
    ¼Ó°£±³¹è(áÕÊàÎßÛÕ).
  • immunity, cross
    ±³Â÷¸é¿ª
  • incision, cross hatching
    ±³Â÷Àý°³(¼ú)
  • plasma cross matching
    Ç÷Àå±³Â÷½ÃÇè(úìíìÎßó©ãËúÐ).
  • helper phage
    Á¶·ÂÆÄÁö
  • inducible phage
    À¯¹ß°¡´ÉÆÄÁö
  • phage
    ÆÄÁö.
  • phage
    ÆÄÁö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion, phage
    ÆÄÁöÀüȯ
  • defective phage
    °á¼ÕÆÄÁö
  • donor-specific phage
    °ø¿©±ÕƯÀÌÆÄÁö
  • helper phage
    Á¶·ÂÆÄÁö
  • inducible phage
    À¯¹ß°¡´ÉÆÄÁö
  • lambda (¥ë) phage
    ¶÷´ÙÆÄÁö, ¥ëÆÄÁö
  • latent phage
    ÀẹÆÄÁö
  • lysogenic phage
    ¿ë¿ø¼ºÆÄÁö
  • mu (¥ì) phage
    ¹ÂÆÄÁö, ¥ìÆÄÁö
  • phage
    ÆÄÁö
  • phage
    ÆÄÁö.
  • phage conversion
    ÆÄÁö±³È¯(¡­Îßüµ).
  • phage conversion
    ÆÄÁö±³È¯(¡­Îßüµ).
  • phage genome
    ÆÄÁö°Ô³ð
  • phage map
    ÆÄÁöÀ¯ÀüÀÚÁöµµ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cross copulation
    ±³Â÷±³¹Ì
  • cross fertilization
    ±³Â÷¼öÁ¤
  • cross protection
    ±³Â÷¹æ¾î
  • cross resistance
    ±³Â÷ÀúÇ×
  • maltese cross
    ¸ôŸ½ÊÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phage cross
    ÆäÀÌÁö ±³Â÷(Îßó©)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • converting phage
    Àüȯ(ï®üµ) ÆäÀÌÁö
  • cryptogenic phage
    ÀáÀç¿ø(íÖî¤ê«) ÆäÀÌÁö
  • DNA phage
    DNA ÆäÀÌÁö (ÔÒ) a DNA-containing phage
  • filamentous phage
    Çʶó¸àÆ®Çü(û¡) ÆäÀÌÁö
  • helper phage
    µµ¿òÀÌ ÆäÀÌÁö
  • homoimmune phage
    µ¿Á¾¸é¿ª(ÔÒðúØóæ¹) ÆäÀÌÁö
  • phage
    ÆäÀÌÁö
  • phage conversion
    "ÆäÀÌÁö Àüȯ(ï®üµ), ÆäÀÌÁö º¯È¯(ܨüµ)"
  • phage induction
    ÆäÀÌÁö À¯µµ(ë¯Óô)
  • phage lambda
    ¶÷´Ù ÆäÀÌÁö
  • phage lysate
    ÆäÀÌÁö ¿ëÇØ¹°(éÁú°Úª)
  • phage lysozyme
    ÆäÀÌÁö ¶óÀ̼ÒÀÚÀÓ
  • phage M13
    M13 ÆäÀÌÁö
  • phage MS-2
    MS-2 ÆäÀÌÁö
  • phage Qb
    Qb ÆäÀÌÁö
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cross
    ±³Â÷, ±³¹è, ±³Àâ
  • cross link
    ±³Â÷°áÇÕ, Ⱦ°áÇÕ
  • cross matching
    ±³Â÷ÀûÇÕ½ÃÇè¹ý
  • cross relaxation
    ±³Â÷ ÀÌ¿Ï
  • cross section radiography
    ´ÜÃþÃÔ¿µ¼ú
  • cross sectional echocardiography
    ´ÜÃþ½ÉÃÊÀ½ÆÄ°Ë»ç
  • cross talk
    ±³Â÷´ëÈ­
  • cross-section
    Ⱦ´Ü¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SPL skin potential level; sound pressure level; splanchnic; spontaneous lesion; staphylococcal phage lys...
Tb Tbilisi [phage]; terbium; tubercle bacillus; tuberculosis
CREG Cross REactive Group (of HLA Antigens)
IRC International Red Cross
ANRC American National Red Cross
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PT Phage Type
PT 4 Phage type 4
ARC American Red Cross
BCF Beat cross frequency
CP-MAS Cross Polarisation Magic Angle Spinning
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • donor-specific phage
    °ø¿©±Õ ƯÀÌ ÆÄÁö
  • lambda phage
    ¶÷´Ù ÆÄ¾ÆÁö
  • phage
    ÆÄ¾ÆÁö
  • phage typing
    ÆÄ¾ÆÁö Çü¹ú, ÆäÀÌÁö Çü
    ÆÄÁö¿¡ ´ëÇÑ °¨¼ö¼º À¯¹«¿¡ µû¶ó ¼¼±ÕÀ» ºÐ·ù, Çüº°ÇÏ´Â ¹æ¹ýÀ» ÆÄÁöÇüº°À̶ó°í ÇÑ´Ù. Àü¿° °æ·Î¸¦ Á¶»çÇÏ´Â µîÀÇ ¿ªÇÐÀû ¿¬±¸¿¡ ÀÌ¿ëµÇ°í ÀÖ´Ù. ÆÄÁö °¨¼ö¼ºÀ» Á¶»çÇÏ´Â °æ¿ì¿¡´Â ÀϹÝÀûÀ¸·Î ¼¼±ÕÀ» ÆòÆÇ ¹èÁö¿¡ ½É¾î ±× À§¿¡ Àû´ç ³óµµÀÇ ÆÄÁö¾×À» ÇÑ ¹æ¿ï ¶³¾î¶ß·Á ¹è¾çÇØ¼­, ±× ºÎºÐÀÇ ¿ë±ÕÀÇ À¯¹«¿¡ ÀÇÇØ¼­ ÆÇÁ¤ÇÑ´Ù. Æ÷µµ ±¸±ÕÀÇ ÆÄÁö Çüº°À» Àß È®¸³µÇ¾î ÀÖÀ¸¸ç ¿ë±ÕÀÇ ÆÐÅÏ¿¡ µû¶ó¼­ 1, 2, 3, 4 ¹× È¥ÇÕ±ºÀ¸·Î ºÐ·ùµÇ°í ÀÖ´Ù. Çüº° ºÒ´ÉÇÑ ±ÕÁÖµµ ÀÖ´Ù. ±× ¿Ü¿¡ À导ÇÁ½º±Õ, µðÇÁÅ׸®¾Æ±Õ, ·»¼­±¸±Õ, ÄÝ·¹¶ó±Õ, Ç×»ê±Õ µî¿¡ ´ëÇØ¼­µµ ½ÃµµµÇ°í ÀÖ´Ù.
  • wear phage
    ±³¸ð»ó
    ÀúÀÛ, ¿¬ÇÏ, ÀÚÀÛ È¸·Î ¸»±â¿¡ À־ Ä¡¾Æ Á¢ÃËÀ̳ª À½½ÄÀÇ ¸¶¸ð ÀÛ¿ë ¶§¹®¿¡ ±³ÇÕ ¸é¿¡ ³ªÅ¸³ª´Â ±³¸ð. ´Ù³â°£ ÇϾǰñÀÌ ÇàÇÏ´Â ±â´ÉÀû ¶Ç´Â ºñ±â´ÉÀû ¿îµ¿À¸·Î ³ªÅ¸³ª¸ç, ±³ÇÕ¸éÀÇ ±³¸ð´Â ¿¬·ÉÀûÀÎ º¯È­ ¶§¹®ÀÌ´Ù.
  • blue cross
    û½ÊÀÚ
  • cross
    ±³Â÷, ±³¹è, ±³Àâ
    ½ÊÀÚÀÇ Çüųª ±¸Á¶. ±³¹è¿¡ ÀÇÇØ ¸¸µé¾îÁø »ý¹°. ±³¹è ¹æ¹ý.
  • cross adaptation
    ±³Â÷ ¼øÀÀ
  • cross arch bar splint
    ¾Ç±³´ë ¿¬°á °íÁ¤ ÀåÄ¡
  • cross arch stabilization
    Ⱥ´ç Ä¡¿­±Ã ¾ÈÁ¤
  • cross bite occlusion
    ±³Â÷ ±³ÇÕ
  • cross contamination
    ±³Â÷ ¿À¿°
  • cross fire technique
    ½ÊÀÚÆ÷È­ Á¶»ç¹ý
  • cross heredity
    ±³Â÷ À¯Àü, ±³Â÷¼º À¯Àü
  • cross incision
    ½ÊÀÚ Àý°³
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
b phage b corynebacteriophage
virulent phage mutant A mutant of a phage that is unable to establish lysogeny.
(05 Mar 2000)
charon phage A cloning vector made from the virus bacteriophage lambda that is used to clone DNA.
(09 Oct 1997)
phage 1. Synonym for bacteriophage.
2. <suffix> Eating, devouring.
Origin: L. Phagedaena, Gr Phago, To eat.
(20 Jun 2000)
phage integrase family <enzyme> Enzymes that mediate site specific recombination in prokaryotes. They fall into two families, phage integrases and resolvases.
(18 Nov 1997)
phage typing <microbiology> Bacteria may be typed by their susceptibility to a range of bacteriophages though confusion may arise if the bacteria carry plasmids encoding restriction endonucleases.
(18 Nov 1997)
helper phage A virus which helps a separate and unrelated defective virus reproduce by infecting the same host cell that is already occupied by the defective virus and providing the proteins which the defective virus is missing and needs to complete its life cycle.
(09 Oct 1997)
ssDNA phage <molecular biology> Single strand DNA phages such as MS2, FX174, as opposed to double stranded DNA phages or RNA phages.
(10 Mar 1998)
defective phage A temperate bacteriophage mutant whose genome does not contain all of the normal components and cannot become fully infectious virus, yet can replicate indefinitely in the bacterial genome as defective probacteriophage; many defective bacteriophage's are mediators of transduction.
Synonym: defective phage.
(05 Mar 2000)
q beta phage <molecular biology> A single-stranded RNA phage that specifically infects enterobacteria containing the f plasmid. It is widely used to study RNA phage and bacterial cell function.
(10 Oct 1997)
tailed phage A member of a group of hundreds of DNA-based bacteria-infecting viruses which are characterised by a helix-shaped tail and a cube-shaped head.This group includes the viral families Myoviridae, Podoviridae, andSiphoviridae.
(09 Oct 1997)
temperate phage A bacteriophage that integrates its DNA into that of the host (lysogeny) as opposed to virulent phages that lyse the host.
(18 Nov 1997)
T even phage <microbiology> A group of dsDNA bacteriophages of enterobacteria including T2, T4, T6 as opposed to T odd phage (T1, 3, 5 and 7)
(18 Nov 1997)
lambda phage <virology> Bacterial DNA virus, first isolated from E. Coli. Its structure is similar to that of the T even phages.
Lambda genetic material consists of a double-stranded DNA molecule with 5' twelve-base-pair sticky ends, known as cos sites, which permit circularisation of the DNA molecule. It shows a lytic cycle and a lysogenic cycle and studies on the control of these alternative cycles have been very important for our understanding of the regulation of gene transcription.
It is used as a cloning vector, accommodating fragments of DNA up to 15 kilobase pairs long. For larger pieces, the cosmid vector was constructed from its ends.
(14 Mar 2000)
lytic phage A bacteriophage (virus which infects bacteria) that can only follow the lytic pathway to completing its lytic cycle, and does not have the mechanisms to enter the lysogenic pathway.
(09 Oct 1997)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
phage cross 1. a phage (bacteriophage) having genes from two or more parental phages as a result of infection by the parent phages of a single bacterial cell; it is a result of recombination. 2. the process of formation of a phage cross.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phage
    =bacteriophage
  • cross
    °Ç³Ê´Ù,Ⱦ´ÜÇÏ´Ù
  • cross-bar
    °¡·ÎÀå
  • cross-country
    µéÆÇÀ» °¡·ÎÁö¸£´Â
  • cross-examination
    ¹Ý´ë ½É¹®
  • cross-examine
    ¿¡ ¹Ý´ë ½É¹®ÇÏ´Ù
  • cross-eyed
    »çÆÈ¶ß±â
  • cross-grained
    °áÀÌ ºÒ±ÔÄ¢ÇÑ
  • cross-purpose
    ¹Ý´ëÀÇ ¸ñÀû
  • cross-question
    ¹Ý´ë ½É¹®
  • Celtic cross
    ÄÌÆ® ½ÊÀÚ°¡(Á߽ɿ¡ ringÀÌ ÀÖÀ½)
  • Charing Cross
    丵 Å©·Î½º(·±´ø½ÃÀÇ Áß¾Ó,Strand°¡ ¼­ÂÊ ³¡ÀÇ ¹øÈ­ ±¸¿ª)
  • Geneva cross
    Àû½ÊÀÚ
  • George Cross
    Á¶Áö ÈÆÀå(George 4¼¼¶§ Á¦Á¤ 1943)
  • Greek cross
    ±×¸®½º ½ÊÀÚ°¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á